CN1251766A - 解热抗感染青银注射液及其制备方法 - Google Patents
解热抗感染青银注射液及其制备方法 Download PDFInfo
- Publication number
- CN1251766A CN1251766A CN 98121802 CN98121802A CN1251766A CN 1251766 A CN1251766 A CN 1251766A CN 98121802 CN98121802 CN 98121802 CN 98121802 A CN98121802 A CN 98121802A CN 1251766 A CN1251766 A CN 1251766A
- Authority
- CN
- China
- Prior art keywords
- flos lonicerae
- water
- herba artemisiae
- artemisiae annuae
- qingyin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 12
- 239000007924 injection Substances 0.000 title claims abstract description 11
- 238000002347 injection Methods 0.000 title claims abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 13
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 9
- 208000021760 high fever Diseases 0.000 claims abstract description 8
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 claims abstract description 7
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 claims abstract description 7
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 claims abstract description 7
- 229940074393 chlorogenic acid Drugs 0.000 claims abstract description 7
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 claims abstract description 7
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 claims abstract description 7
- 235000001368 chlorogenic acid Nutrition 0.000 claims abstract description 7
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 7
- 239000000787 lecithin Substances 0.000 claims description 7
- 235000010445 lecithin Nutrition 0.000 claims description 7
- 229940067606 lecithin Drugs 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 210000003022 colostrum Anatomy 0.000 claims description 6
- 235000021277 colostrum Nutrition 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 5
- 239000000706 filtrate Substances 0.000 claims description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 5
- 229920000053 polysorbate 80 Polymers 0.000 claims description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 238000005360 mashing Methods 0.000 claims description 3
- 239000012567 medical material Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 238000001291 vacuum drying Methods 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 2
- 238000004659 sterilization and disinfection Methods 0.000 claims description 2
- 239000000470 constituent Substances 0.000 claims 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 abstract description 9
- 206010057190 Respiratory tract infections Diseases 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 5
- 206010011224 Cough Diseases 0.000 abstract description 4
- 239000007927 intramuscular injection Substances 0.000 abstract description 4
- 238000010255 intramuscular injection Methods 0.000 abstract description 4
- 238000001990 intravenous administration Methods 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 3
- 230000001154 acute effect Effects 0.000 abstract description 3
- 231100000869 headache Toxicity 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 206010063659 Aversion Diseases 0.000 abstract description 2
- 206010028748 Nasal obstruction Diseases 0.000 abstract description 2
- 206010039101 Rhinorrhoea Diseases 0.000 abstract description 2
- 208000010753 nasal discharge Diseases 0.000 abstract description 2
- 210000004243 sweat Anatomy 0.000 abstract description 2
- 230000035922 thirst Effects 0.000 abstract description 2
- 235000001405 Artemisia annua Nutrition 0.000 abstract 2
- 240000000011 Artemisia annua Species 0.000 abstract 2
- 241000245240 Lonicera Species 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000032376 Lung infection Diseases 0.000 abstract 1
- 230000002155 anti-virotic effect Effects 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 208000028659 discharge Diseases 0.000 abstract 1
- 230000035622 drinking Effects 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000003381 solubilizing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 23
- 239000003814 drug Substances 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 229940079593 drug Drugs 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 206010035664 Pneumonia Diseases 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 229940090044 injection Drugs 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 206010020741 Hyperpyrexia Diseases 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000002510 pyrogen Substances 0.000 description 4
- 206010002199 Anaphylactic shock Diseases 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical group [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 230000005180 public health Effects 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 239000009916 yin-huang Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 229940124584 antitussives Drugs 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229940124587 cephalosporin Drugs 0.000 description 2
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000008588 hemolysis Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 238000005057 refrigeration Methods 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000026344 Nasal disease Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 238000011951 anti-virus test Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000011976 chest X-ray Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 239000009254 shuang-huang-lian Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98121802A CN1072951C (zh) | 1998-10-20 | 1998-10-20 | 解热抗感染青银注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98121802A CN1072951C (zh) | 1998-10-20 | 1998-10-20 | 解热抗感染青银注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1251766A true CN1251766A (zh) | 2000-05-03 |
CN1072951C CN1072951C (zh) | 2001-10-17 |
Family
ID=5227304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98121802A Expired - Lifetime CN1072951C (zh) | 1998-10-20 | 1998-10-20 | 解热抗感染青银注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1072951C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100352487C (zh) * | 2005-06-25 | 2007-12-05 | 向迪凯 | 一种治疗慢性鼻、咽炎和梅核气的中药 |
CN100367979C (zh) * | 2004-10-29 | 2008-02-13 | 张平 | 一种清热、抗菌、抗病毒的冻干粉针剂及其制备方法 |
CN1772073B (zh) * | 2005-10-24 | 2010-09-08 | 泸州医学院 | 一种治疗咽喉口腔疾病的药物组合物与其制备工艺 |
CN104666431A (zh) * | 2015-02-16 | 2015-06-03 | 广西双蚁药业有限公司 | 一种治疗急性上呼吸道感染的中药制剂及其生产方法 |
-
1998
- 1998-10-20 CN CN98121802A patent/CN1072951C/zh not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100367979C (zh) * | 2004-10-29 | 2008-02-13 | 张平 | 一种清热、抗菌、抗病毒的冻干粉针剂及其制备方法 |
CN100352487C (zh) * | 2005-06-25 | 2007-12-05 | 向迪凯 | 一种治疗慢性鼻、咽炎和梅核气的中药 |
CN1772073B (zh) * | 2005-10-24 | 2010-09-08 | 泸州医学院 | 一种治疗咽喉口腔疾病的药物组合物与其制备工艺 |
CN104666431A (zh) * | 2015-02-16 | 2015-06-03 | 广西双蚁药业有限公司 | 一种治疗急性上呼吸道感染的中药制剂及其生产方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1072951C (zh) | 2001-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100348258C (zh) | 一种治疗上呼吸道感染的药物及其制备方法 | |
CN101209330A (zh) | 一种具有清热解毒、驱虫保肝功效的复方中药颗粒剂 | |
CN102319294A (zh) | 双香草制剂及其制备方法 | |
CN101480451A (zh) | 一种治疗上呼吸道感染的配方及其应用 | |
CN101332256B (zh) | 用于鸡传染性法氏囊炎的中药组合物及制备方法 | |
CN101703601B (zh) | 预防和治疗鸡败血支原体病的中药组合物及其制备方法 | |
CN1072951C (zh) | 解热抗感染青银注射液及其制备方法 | |
CN111329982A (zh) | 小柴胡颗粒联合磷酸氯喹的新应用 | |
CN109432287B (zh) | 一种防治家禽气分热盛证的中药口服液及其制备方法 | |
CN101607032B (zh) | 治疗儿童咳嗽的复方药物及其制备方法 | |
CN115721677B (zh) | 用于防治犊牛细菌性腹泻的中药组合物及其制备方法和应用 | |
CN105343503B (zh) | 一种治疗咽喉炎的药物组合物及其应用 | |
CN104352582A (zh) | 一种防治鸡大肠杆菌的药物及其制备方法 | |
CN100339126C (zh) | 一种治疗和预防胆道炎症的中药及其制备工艺 | |
CN116270801B (zh) | 一种中药组合物及其制备和应用 | |
CN110974878B (zh) | 一种治疗绿壳蛋鸡鼻气管鸟疫杆菌病的中药喷雾剂及其制备方法 | |
CN112870250B (zh) | 防治器官纤维化的组合物及其应用与制剂 | |
CN1548041A (zh) | 一种穿心莲制备物及其制备方法,以及该制备物在制药中的应用 | |
CN101375931A (zh) | 一种具有清热利湿功效的中药口服液及其在畜禽上的应用 | |
CN101862392B (zh) | 鱼腥草防治血栓的新制药用途 | |
CN104623351B (zh) | 治疗慢性咽炎的药物组合物 | |
CN101209310A (zh) | 一种用于治疗奶牛乳房炎的复方中药注射剂 | |
CN114099608A (zh) | 一种含寒水石的抗病毒抗菌中药组合物及其制备方法和应用 | |
CN105030887A (zh) | 一种治疗小儿湿热型腹泻的中药制剂及其制备方法 | |
CN115671192A (zh) | 一种防治鸭绦虫病的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JINDING UNITED FIBER TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: LUZHOU MEDICAL COLLEGE Effective date: 20040924 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20040924 Address after: 210009 No. 238, Central Road, Nanjing, Jiangsu Patentee after: Technology Centre of Jinling Pharmaceutical Co., Ltd. Address before: 646000 loyalty hill, Luzhou, Sichuan Patentee before: Luzhou Medical College |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20011017 |